State Street Corp Blueprint Medicines Corp Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, State Street Corp holds 2,500,207 shares of BPMC stock, worth $236 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,500,207

Previous 2,765,702 9.6%

Holding current value

$236 Million

Previous $256 Million 14.72%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$82.48 - $101.39 $21.9 Million - $26.9 Million	-265,495 Reduced 9.6%	2,500,207 $218 Million
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $32.4 Million - $46.5 Million	385,818 Added 16.21%	2,765,702 $256 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $15.9 Million - $20.4 Million	187,182 Added 8.54%	2,379,884 $257 Million
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $16.9 Million - $23.1 Million	-231,498 Reduced 9.55%	2,192,702 $208 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $8.85 Million - $18.7 Million	-201,427 Reduced 7.67%	2,424,200 $224 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $5.75 Million - $8.09 Million	122,634 Added 4.9%	2,625,627 $132 Million
Q2 2023 Aug 14, 2023	SELL	$42.2 - $66.37 $10.6 Million - $16.7 Million	-252,286 Reduced 9.16%	2,502,993 $158 Million
Q1 2023 May 15, 2023	SELL	$37.97 - $50.0 $3.02 Million - $3.98 Million	-79,642 Reduced 2.81%	2,755,279 $124 Million
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $25.3 Million - $40.9 Million	615,123 Added 27.71%	2,834,921 $124 Million
Q3 2022 Nov 15, 2022	SELL	$49.93 - $77.7 $24.8 Million - $38.6 Million	-496,744 Reduced 18.29%	2,219,798 $146 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $20.3 Million - $31.5 Million	449,648 Added 19.84%	2,716,542 $137 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $29 Million - $58.9 Million	535,424 Added 30.92%	2,266,894 $145 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $4.06 Million - $5 Million	43,086 Added 2.55%	1,731,470 $185 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $3.17 Million - $4.28 Million	39,138 Added 2.37%	1,688,384 $174 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $10.9 Million - $13.3 Million	131,741 Added 8.68%	1,649,246 $145 Million
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $10.3 Million - $12.3 Million	-113,522 Reduced 6.96%	1,517,505 $148 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $16.8 Million - $22.7 Million	-182,261 Reduced 10.05%	1,631,027 $183 Million
Q3 2020 Nov 10, 2020	SELL	$66.45 - $92.7 $4.56 Million - $6.36 Million	-68,558 Reduced 3.64%	1,813,288 $168 Million
Q2 2020 Aug 14, 2020	SELL	$57.09 - $79.27 $4.45 Million - $6.18 Million	-77,995 Reduced 3.98%	1,881,846 $147 Million
Q1 2020 May 11, 2020	BUY	$48.11 - $82.22 $94.3 Million - $161 Million	1,959,841 New	1,959,841 $115 Million

Others Institutions Holding BPMC

# of Institutions

380

Shares Held

65.9M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.63B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Blueprint Medicines Corp Transaction History